These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25194591)

  • 21. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage.
    Franco L; Benedetti R; Ferek GA; Massouh E; Fló J
    Cell Immunol; 1998 Nov; 190(1):1-11. PubMed ID: 9826441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of immune responses in pigs following oral administration of purified F4 fimbriae.
    Van den Broeck W; Cox E; Goddeeris BM
    Vaccine; 1999 Apr; 17(15-16):2020-9. PubMed ID: 10217602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice.
    Shahiwala A; Amiji MM
    J Drug Target; 2008 May; 16(4):302-10. PubMed ID: 18446609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Volckmar J; Knop L; Stegemann-Koniszewski S; Schulze K; Ebensen T; Guzmán CA; Bruder D
    Vaccine; 2019 Aug; 37(35):4963-4974. PubMed ID: 31320219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Adjuvants Polyphosphazene (PCEP) and a Combination of Curdlan Plus Leptin Promote a Th17-Type Immune Response to an Intramuscular Vaccine in Mice.
    Chaffey A; Hamonic G; Chand D; Mutwiri GK; Wilson HL
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34069081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
    Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
    Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens.
    Mowat AM; Maloy KJ; Donachie AM
    Immunology; 1993 Dec; 80(4):527-34. PubMed ID: 7508416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired mucosal immune responses in interleukin 4-targeted mice.
    Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
    J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of immunological tolerance by oral, but not intravenous and intraportal, administration of ovalbumin and the difference between young and old mice.
    Wakabayashi A; Utsuyama M; Hosoda T; Sato K; Takahashi H; Hirokawa K
    J Nutr Health Aging; 2006; 10(3):183-91. PubMed ID: 16622581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of age and maternal antibodies on the systemic and mucosal immune response after neonatal immunization in a porcine model.
    Guzman-Bautista ER; Garcia-Ruiz CE; Gama-Espinosa Al; Ramirez-Estudillo C; Rojas-Gomez OI; Vega-Lopez MA
    Immunology; 2014 Apr; 141(4):609-16. PubMed ID: 24754050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The identification of plant lectins with mucosal adjuvant activity.
    Lavelle EC; Grant G; Pusztai A; Pfüller U; O'Hagan DT
    Immunology; 2001 Jan; 102(1):77-86. PubMed ID: 11168640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
    Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
    J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.